Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Finasteride reduces melanin production, possibly treating hyperpigmentation and melanoma, but needs more safety research.

Human skin's melanocytes respond to light by changing shape, producing pigments and hormones, which may affect sleep patterns.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

Vitamin E and C may help slow Alzheimer's and Parkinson's progression.

Lower ghrelin levels and certain gene variations may increase acne risk.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Levetiracetam often causes behavioral issues, while oxcarbazepine is more likely to cause sleepiness in epilepsy patients.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

Scientists created a model using sheep cells to study hair root formation, which can test how different substances affect hair growth.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Vogt-Koyanagi-Harada disease affects vision and skin, mainly in people with darker skin, and is treated with steroids and immunosuppressants.

Rizatriptan benzoate-loaded dissolving microneedles are effective and convenient for treating acute migraines.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Ethosomal carriers effectively deliver hair loss drug into skin.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

Blocking interferon-gamma might help treat various autoimmune diseases.

Blocking adenosine A2B receptor may prevent or treat hearing loss.

Increased PPARGC1α relates to hair thinning in common baldness.

Activating the Nrf2 pathway reduces inflammation and cell activation in human hair follicles, suggesting a potential treatment for certain hair loss conditions.

Smaller finasteride particles increase effectiveness in treating hair loss.

A protein called sFRP4 from skin cells stops the development of pigment-producing cells in hair.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

Different cell types work together to repair skin, and targeting them may improve healing and reduce scarring.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.